Cholesterol Shield Ingredients & Drug Interactions
by Nature's Way
What is this page for?
First and foremost: checking Cholesterol Shield against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
Cholesterol Shield is a dietary supplement by Nature's Way with 7 active ingredients. Its ingredients are commonly taken for replacing fluids and electrolytes, preventing dehydration during exercise or illness, treating low blood sodium (under medical care).Based on those ingredients, 322 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Sodium, Pantesin. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against Cholesterol Shield by Nature's Way
Ask about any prescription or over-the-counter medication and we check it for interactions with Cholesterol Shield by Nature's Way — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of Cholesterol Shield by Nature's Way
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Low disclosure
Cholesterol Shield contains 7 active ingredients. The main ones are beta-sitosterol and a proprietary blend of other plant sterols — compounds from plants that work like cholesterol in your body and help lower your cholesterol levels.
Pantesin (also called pantethine) is a form of vitamin B5 that may help with cholesterol and fat levels. Sodium is included as well.
The tablet also contains inactive ingredients — cellulose, sodium croscarmellose, silica, magnesium stearate, hypromellose, and glycerin — which are standard binders, fillers, and capsule materials.
Does it work?
Moderate evidence
Beta-sitosterol is likely effective for benign prostate enlargement and possibly effective for familial high cholesterol and heart disease. Pantesin (pantethine) is possibly effective for high triglycerides and cholesterol.
The evidence we hold doesn't establish effectiveness for the other plant sterols in this product's proprietary blend, and there isn't enough reliable evidence to rate pantethine for athletic performance or some types of high cholesterol.
How safe is it?
Well-documented data
Beta-sitosterol is generally well tolerated but may cause gas, constipation, diarrhea, indigestion, nausea, or loss of appetite. There's one case report of acute pancreatitis linked to it.
Avoid beta-sitosterol during pregnancy and breastfeeding — there isn't enough safety data. Pantesin is also generally well tolerated but can cause bloating, diarrhea, nausea, vomiting, gas, and stomach discomfort.
Pantesin safety during pregnancy and breastfeeding hasn't been well studied, so caution is advised. Sodium in normal dietary amounts is fine, but too much is linked to high blood pressure and heart strain — avoid sodium supplements or very high intake without medical advice.
At very high intakes, sodium is linked to worsening cardiovascular disease, high blood pressure, and kidney disease.
Meds to double-check
Moderate interaction found
Blood thinners and antiplatelet drugs (like warfarin, clopidogrel, or aspirin) need a Major caution — pantesin may increase bleeding risk. Blood pressure medications need a Moderate caution because sodium can reduce their effectiveness.
Also check with your pharmacist if you take lithium, corticosteroids, didanosine, sodium phosphate bowel prep, tolvaptan, or any other sodium-containing medications.
The bottom line
Scorecard at a glanceFormula with limited ingredient disclosure with some supporting evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.
If you take blood thinners, blood pressure medications, lithium, or other sodium-containing drugs, talk to your pharmacist or doctor before starting. Beta-sitosterol and pantesin may help with cholesterol levels, but pregnancy, breastfeeding, and any active medical conditions need personalized advice.
Check your exact medications with the tool on this page.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 3 of 7 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Sep 25, 2025.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about Cholesterol Shield, straight from the product label.
| Brand | Nature's Way |
|---|---|
| Net contents | 90 Tablet(s) |
| Market status | On market |
| Date entered into DSLD | Sep 25, 2025 |
| DSLD ID | 337209 |
| Product type | Other Combinations |
| Supplement form | Tablet Or Pill |
| Dietary claims / uses | Nutrient, All Other, Structure/Function |
| Intended target group(s) | Vegan, Vegetarian, Adult (18 - 50 Years), Gluten Free, Dairy Free |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for Cholesterol Shield by Nature's Way, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Sodium | 5 mg | 1% |
| Proprietary Phytosterol Blend | 400 mg | -- |
| Beta-Sitosterol | 0 NP | -- |
| Campesterol | 0 NP | -- |
| Stigmasterol | 0 NP | -- |
| Brassicasterol | 0 NP | -- |
| Other Plant Sterols | 0 NP | -- |
| Pantesin | 200 mg | -- |
Other ingredients: Cellulose, Sodium Croscarmellose, Silica, Magnesium Stearate, Hypromellose, Glycerin
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formulation
Supports healthy cholesterol levels already within normal range Supports healthy cholesterol metabolism
V Vegan Gelatin free
V Vegan Gelatin free
Supports heart health plus supports healthy cholesterol levels already within normal range
Gluten free. No wheat, dairy, gelatin, or artificial colors.
Formula
Combines beneficial plant sterols and pantethine Plant phytosterols help limit absorption of cholesterol from food
Phytosterol blend
Seals/Symbols
V Vegan Gelatin free
General Statements
50% Bottle made from 50% post-consumer recycled plastic
Heart matters
FDA Disclaimer Statement
These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
FDA Statement of Identity
Dietary Supplement
Suggested/Recommended/Usage/Directions
Recommendation: Adults take 1 tablet three times daily, with or immediately before each meal.
Precautions
If you are pregnant, nursing, or taking any medications, consult a healthcare professional before use.
Keep out of reach of children.
Safety sealed with inner seal. Do not use if seal is broken or missing.
Storage
Keep tightly closed. Store at room temperature. Avoid excessive heat and direct sunlight
Brand IP Statement(s)
Pantesin is a registered trademark of Kyowa Pharma Chemical Co., Ltd.
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
Cholesterol Shield by Nature's Way label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in Cholesterol Shield by Nature's Way
These are the 7 active ingredients this product is made of. Select any to open its full monograph.
Serving size1 Tablet(s) Dosage formTablet Or Pill Servings per container90 Amounts shown are per serving.
Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.
Sodium
Interacts with205 drugs
Sodium is an essential mineral and electrolyte your body needs to balance fluids, support nerves, and help muscles work. Most people in modern diets g...
Sodium monograph & interactionsProprietary Phytosterol Blend
- › Beta-Sitosterol
- › Campesterol
- › Stigmasterol
- › Brassicasterol
- › Other Plant Sterols
Pantesin
Interacts with122 drugs
Pantethine is a derivative of vitamin B5 (pantothenic acid) that some studies suggest may modestly lower cholesterol and triglycerides. The evidence i...
Pantesin monograph & interactionsOther (inactive) ingredients: Cellulose, Sodium Croscarmellose, Silica, Magnesium Stearate, Hypromellose, Glycerin. These complete the product’s ingredient list but are not active constituents.
Cholesterol Shield by Nature's Way Drug Interactions
HelloPharmacist Interaction Report
Cholesterol Shield by Nature's Way does interact with several medication types, mainly through its sodium content.
The most serious concern is with blood thinners and antiplatelet drugs (like warfarin or aspirin) — the pantethine ingredient may increase bleeding risk by reducing how your blood clots.
Read the full breakdown — every affected drug type, severity by severity
Sodium in this product can lower the effectiveness of blood pressure medications (antihypertensives) and may interfere with lithium, a mood stabilizer used for bipolar disorder. It can also raise sodium levels too high when combined with corticosteroids, didanosine (an HIV medication), sodium phosphate bowel-prep solutions, tolvaptan, or other sodium-containing drugs — a condition called hypernatremia that can cause serious problems.
Altogether, these interactions span 320 individual medications. Check your exact prescriptions with the search tool below before starting this product.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against Cholesterol Shield?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in Cholesterol Shield interact with 322 drugs. Click any drug to see the details.
2 of the 7 ingredients in Cholesterol Shield interact with drugs. Each result below shows which ingredient is responsible. Sodium Pantesin
AbciximabReoPro
How Abciximab interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Abciximab interactionAbrocitinibCibinqo
How Abrocitinib interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Abrocitinib interactionAcebutololRhotral, Sectral
How Acebutolol interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Acebutolol interactionAcenocoumarolSintrom
How Acenocoumarol interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Acenocoumarol interactionAcetaminophen, AspirinGemnisyn
How Acetaminophen, Aspirin interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Acetaminophen, Aspirin interactionAcetaminophen, Aspirin, CaffeineExcedrin, Excedrin Extra Strength, Excedrin Migraine
How Acetaminophen, Aspirin, Caffeine interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Acetaminophen, Aspirin, Caffeine interactionAcetaminophen, IbuprofenCombogesic
How Acetaminophen, Ibuprofen interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Acetaminophen, Ibuprofen interactionAcetazolamideAk-Zol, Diamox
How Acetazolamide interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Acetazolamide interactionAcetylsalicylic AcidEntrophen
How Acetylsalicylic Acid interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Acetylsalicylic Acid interactionAliskirenTekturna
How Aliskiren interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Aliskiren interactionAlteplase, TpaActilyse, Activase
How Alteplase, Tpa interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Alteplase, Tpa interactionAluminum Hydroxide, Aspirin, Codeine Phosphate, Magnesium HydroxideAscriptin Codeine #2
How Aluminum Hydroxide, Aspirin, Codeine Phosphate, Magnesium Hydroxide interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Aluminum Hydroxide, Aspirin, Codeine Phosphate, Magnesium Hydroxide interactionAluminum Hydroxide, Aspirin, Magnesium HydroxideAscriptin
How Aluminum Hydroxide, Aspirin, Magnesium Hydroxide interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Aluminum Hydroxide, Aspirin, Magnesium Hydroxide interactionAmbrisentanLetairis, Volibris
How Ambrisentan interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Ambrisentan interactionAmilorideAmilamont, Midamor
How Amiloride interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Amiloride interactionAmiloride, HydrochlorothiazideAmil-Co, Amilzide, Moduret 25, Moduretic
How Amiloride, Hydrochlorothiazide interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Amiloride, Hydrochlorothiazide interactionAmlodipineNorliqva
How Amlodipine interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Amlodipine interactionAmlodipine BenzoateKaterzia
How Amlodipine Benzoate interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Amlodipine Benzoate interactionAmlodipine BesilateIstin
How Amlodipine Besilate interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Amlodipine Besilate interactionAmlodipine BesylateNorvasc
How Amlodipine Besylate interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Amlodipine Besylate interactionAmlodipine Besylate, BenazeprilLotrel
How Amlodipine Besylate, Benazepril interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Amlodipine Besylate, Benazepril interactionAmlodipine, CelecoxibConsensi
How Amlodipine, Celecoxib interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Amlodipine, Celecoxib interactionAmmonium ChlorideAmmonium Chloride
How Ammonium Chloride interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Ammonium Chloride interactionAnacaulase-bcdbNexoBrid
How Anacaulase-bcdb interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Anacaulase-bcdb interactionAnagrelideAgrylin
How Anagrelide interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Anagrelide interactionAnisindioneMiradon
How Anisindione interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Anisindione interactionAntithrombin IiiThrombate III
How Antithrombin Iii interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Antithrombin Iii interactionApixabanEliquis
How Apixaban interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Apixaban interactionAprocitentanTryvio
How Aprocitentan interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
SodiumAntihypertensive Drugs Moderate
Interaction Summary
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
Read the full Sodium + Aprocitentan interactionArgatrobanArgatroban
How Argatroban interacts with Cholesterol Shield — through 1 ingredient. Tap an ingredient for the detail:
PantesinAnticoagulant/antiplatelet Drugs Moderate
Interaction Summary
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Read the full Pantesin + Argatroban interactionEach ingredient & the kinds of drugs it affects
For each ingredient in Cholesterol Shield with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.
Sodium
Antihypertensive Drugs
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
High intake of dietary sodium can increase systolic and diastolic blood pressure. Also, high intake of sodium may necessitate increased use of antihypertensive medications to achieve blood pressure control in some patients, such as those with chronic kidney disease.
Corticosteroids
Concomitant use of mineralocorticoids and some glucocorticoids with sodium supplements might increase the risk of hypernatremia.
Mineralocorticoids and some glucocorticoids (corticosteroids) cause sodium retention. This effect is dose-related and depends on mineralocorticoid potency. It is most common with hydrocortisone, cortisone, and fludrocortisone, followed by prednisone and prednisolone.
Didanosine (Videx)
Concomitant use of didanosine with additional sodium from dietary or supplemental sources may increase the risk of hypernatremia.
Didanosine formulations contain a significant amount of sodium.
Lithium
Altering dietary intake of sodium might alter the levels and clinical effects of lithium.
High sodium intake can reduce plasma concentrations of lithium by increasing lithium excretion. Reducing sodium intake can significantly increase plasma concentrations of lithium and cause lithium toxicity in patients being treated with lithium carbonate. Stabilizing sodium intake is shown to reduce the percentage of patients with lithium level fluctuations above 0.8 mEq/L. Patients taking lithium should avoid significant alterations in their dietary intake of sodium.
Sodium Phosphates
Theoretically, concomitant use of sodium phosphate with sodium supplements might increase the risk of hypernatremia.
Use of high doses (> 45 mL in 24 hours) of sodium phosphate, such as those used for bowel cleansing before surgery, can lead to serious electrolyte disturbances, including hypernatremia. The risk of hypernatremia is highest in the elderly and people with other risk factors for electrolyte disturbances.
Sodium-Containing Drugs
Concomitant use of sodium-containing drugs with additional sodium from dietary or supplemental sources may increase the risk of hypernatremia and long-term sodium-related complications.
The Chronic Disease Risk Reduction (CDRR) intake level of 2.3 grams of sodium daily indicates the intake at which it is believed that chronic disease risk increases for the apparently healthy population. Some medications contain high quantities of sodium. When used in conjunction with sodium supplements or high-sodium diets, the CDRR may be exceeded. Additionally, concomitant use may increase the risk for hypernatremia; this risk is highest in the elderly and people with other risk factors for electrolyte disturbances.
Tolvaptan (Samsca)
Theoretically, concomitant use of tolvaptan with sodium might increase the risk of hypernatremia.
Tolvaptan is a vasopressin receptor 2 antagonist that is used to increase sodium levels in patients with hyponatremia. Patients taking tolvaptan should use caution with the use of sodium salts such as sodium chloride.
Pantesin
Anticoagulant/Antiplatelet Drugs
Theoretically, pantethine might increase the risk of bleeding with anticoagulant or antiplatelet drugs.
Some evidence suggests that pantethine reduces platelet aggregation.
Brand information
Manufacturer and brand details for Cholesterol Shield, from the product label.
Nature's Way
See all Nature's Way products- Name
- Nature's Way Brands, LLC
- City
- Green Bay
- State
- WI
- ZipCode
- 54311
- Phone Number
- 1-800-962-8873
- Web Address
- naturesway.com
Cholesterol Shield by Nature's Way: Common Questions
Does Cholesterol Shield by Nature's Way interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Can I take Cholesterol Shield if I'm pregnant or breastfeeding?
What side effects might I notice?
Does this product actually lower cholesterol?
Is there a lot of sodium in this product?
What are plant sterols and why are they in here?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if Cholesterol Shield is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind Cholesterol Shield’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Sodium
Interacts with 205 drugsSodium is an essential mineral and electrolyte your body needs to balance fluids, support nerves, and help muscles work. Most people in modern diets get more than enough—often too much—from...
Read the full Sodium monograph → Herb & supplement monographBeta-sitosterol
Beta-sitosterol is a plant sterol that may modestly lower LDL ('bad') cholesterol and may help ease urinary symptoms from an enlarged prostate. Evidence is moderate for these uses and weaker...
Read the full Beta-sitosterol monograph → Herb & supplement monographPantethine
Interacts with 122 drugsPantethine is a derivative of vitamin B5 (pantothenic acid) that some studies suggest may modestly lower cholesterol and triglycerides. The evidence is limited and not strong enough to repla...
Read the full Pantethine monograph →Sources & How We Checked
Cholesterol Shield's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 54 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Sodium 38 references
- Garabedian-Ruffalo SM, Ruffalo RL. Drug and nutrient interactions. Am Fam Physician 1986;33:165-74.
- Food and Drug Administration Science Background: Safety of Sodium Phosphates Oral Solution. September 17, 2001. Available at: http://www.fda.gov/cder/drug/safety/sodiumphospate.htm
- Coton T, Mallaret C, Coilliot C, Carre D, Guisset M. Severe acute ulcerated gastritis induced by salt. Presse Med 2009;38(3):499-500. PubMed
- Frings-Meuthen P, Buehlmeier J, Baecker N, et al. High sodium chloride intake exacerbates immobilization-induced bone resorption and protein losses. J Appl Physiol 2011;111(2):537-542. PubMed
- Frings-Meuthen P, Baecker N, Heer M. Low-grade metabolic acidosis may be the cause of sodium chloride-induced exaggerated bone resorption. J Bone Miner Res 2008;23(4):517-524. PubMed
- Alam S, Johnson AG. A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet of blood pressure. J Hum Hypertens 1999;13(6):367-74.
- Boudville N, Ward S, Benaroia M, House AA. Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens 2005;18(10):1300-5. PubMed
- Bennett WM. Drug interactions and consequences of sodium restriction. Am J Clin Nutr 1997;65(2 Suppl):678S-681S. PubMed
- Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994;97(4):383-9. PubMed
- Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, DC: National Academy Press, 2005. Available at: http://www.nap.edu/openbook.php?record_id=10925. DOI
- D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 2012;31(4):489-98. PubMed
- Goldsmith SR. Hyponatremia in heart failure: time for a trial. J Card Fail 2013;19(6):398-400. PubMed
- Willocks L, Brettle R, Keen J, Valentine C, Pinching AJ. Formulations of didanosine (ddI) and salt overload. Lancet 1992;339(8786):190.
- Chen L, Zhang Z, Chen W, Whelton PK, Appel LJ. Lower Sodium Intake and Risk of Headaches: Results From the Trial of Nonpharmacologic Interventions in the Elderly. Am J Public Health. 2016;106(7):1270-5. PubMed
- Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129(9):981-9. PubMed
- Cook NR, Appel LJ, Whelton PK. Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. J Am Coll Cardiol. 2016;68(15):1609-1617. PubMed
- Mente A, O'Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2016;388(10043):465-75. PubMed
- Moosavian SP, Haghighatdoost F, Surkan PJ, Azadbakht L. Salt and obesity: a systematic review and meta-analysis of observational studies. Int J Food Sci Nutr. 2017;68(3):265-277. PubMed
- O'Donnell M, Mente A, Rangarajan S, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371(7):612-23. DOI
- Poggio R, Gutierrez L, Matta MG, Elorriaga N, Irazola V, Rubinstein A. Daily sodium consumption and CVD mortality in the general population: systematic review and meta-analysis of prospective studies. Public Health Nutr. 2015;18(4):695-704. PubMed
- Stallings VA, Harrison M, Oria M; Committee to Review the Dietary Reference Intakes for Sodium and Potassium, Food and Nutrition Board, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Washington (DC): National Acad
- Mahtani KR, Heneghan C, Onakpoya I, et al. Reduced Salt Intake for Heart Failure: A Systematic Review. JAMA Intern Med. 2018 Dec 1;178(12):1693-1700. PubMed
- Yancy CW. Sodium Restriction in Heart Failure: Too Much Uncertainty-Do the Trials. JAMA Intern Med. 2018 Dec 1;178(12):1700-1701. PubMed
- He FJ, Campbell NRC, Ma Y, MacGregor GA, Cogswell ME, Cook NR. Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health. Int J Epidemiol. 2018;47(6):1784-1795. PubMed
- Murthy K, Ondrey GJ, Malkani N, et al. THE EFFECTS OF HYPONATREMIA ON BONE DENSITY AND FRACTURES: A SYSTEMATIC REVIEW AND META-ANALYSIS. Endocr Pract. 2019;25(4):366-378. PubMed
- Messerli FH, Hofstetter L, Syrogiannouli L, et al. Sodium intake, life expectancy, and all-cause mortality. Eur Heart J 2021;42(21):2103-2112. PubMed
- Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev 2020;12(12):CD004022. PubMed
- Giatti S, Santos RB, Aielo AN, et al. Association of sodium with obstructive sleep apnea. The ELSA-Brasil study. Ann Am Thorac Soc 2021;18(3):502-510. PubMed
- Nan X, Lu H, Wu J, et al. The interactive association between sodium intake, alcohol consumption and hypertension among elderly in northern China: a cross-sectional study. BMC Geriatr 2021;21(1):135. PubMed
- Kyozuka H, Fukusda T, Murata T, et al. Impact of preconception sodium intake on hypertensive disorders of pregnancy: The Japan Environment and Children's study. Pregnancy Hypertens 2021;23:66-72. PubMed
- Zhao L, Ogden CL, Yang Q, et al. Association of usual sodium intake with obesity among US children and adolescents, NHANES 2009-2016. Obesity (Silver Spring) 2021;29(3):587-594. PubMed
- Ma Y, He FJ, Sun Q, et al. 24-Hour urinary sodium and potassium excretion and cardiovascular risk. N Engl J Med 2022;386(3):252-263. PubMed
- Liu J, Yang X, Zhang P, et al. Association of urinary sodium excretion and left ventricular hypertrophy in people with type 2 diabetes mellitus: A cross-sectional study. Front Endocrinol (Lausanne) 2021;12:728493. PubMed
- Filippini T, Malavolti M, Whelton PK, Vinceti M. Sodium intake and risk of hypertension: A systematic review and dose-response meta-analysis of observational cohort studies. Curr Hypertens Rep 2022;24(5):133-144. PubMed
- Wang DD, Li Y, Nguyen XT, et al. Dietary sodium and potassium intake and risk of non-fatal cardiovascular diseases: The million veteran program. Nutrients 2022;14(5):1121. PubMed
- Kwak JH, Park CH, Eun CS, et al. The associations of dietary intake of high sodium and low zinc with gastric cancer mortality: A prospective cohort study in Korea. Nutr Cancer 2022;74(10):3501-3508. PubMed
- George S, Maiti R, Mishra BR, Jena M, Mohapatra D. Effect of regulated add-on sodium chloride intake on stabilization of serum lithium concentration in bipolar disorder: A randomized controlled trial. Bipolar Disord 2023;25(1):66-75. PubMed
- Zhou TL, Schütten MTJ, Kroon AA, et al. Urinary Sodium Excretion and Salt Intake Are Not Associated With Blood Pressure Variability in a White General Population. J Am Heart Assoc 2023;12(1):e026578. PubMed
Beta-sitosterol 7 references
- Berges RR, Windeler J, Trampisch HJ, et al. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group. Lancet 1995;345:1529-32.
- Klippel KF, Hiltl DM, Schipp B. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. Br J Urol 1997;80:427-32.
- Wilt TJ, MacDonald R, Ishani A. beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review. BJU Int 1999;83:976-83. PubMed
- Oster P, Schlierf G, Heuck CC, et al. [Sitosterol in familial hyperlipoproteinemia type II. A randomized, double-blind, cross-over study]. Dtsch Med Wochenschr 1976;101:1308-11.
- Becker M, Staab D, Von Bergman K. Long-term treatment of severe familial hypercholesterolemia in children: effect of sitosterol and bezafibrate. Pediatrics 1992;89:138-42. DOI
- Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med 2002
- Lorenze A, Hsueh W, Nasr J. Beta-sitosterol-induced acute pancreatitis: A case report and review of the literature. Cureus. 2020;12(3):e7407. PubMed
Pantethine 9 references
- Da Col PG, Cattin L, Fonda M, et al. Pantethine in the treatment of hypercholesterolemia: a randomized double-blind trial versus tiadenol. Curr Ther Res 1984;36:314-22.
- Rubba P, Postaiglione B, De Simone F, et al. Comparative evaluation of the lipid-lowering effects of fenofibrate and pantethine in type II hyperlipoproteinemia. Curr Ther Res 1985;38:719-27.
- Coronel F, Tornero F, Torrente J, et al. Treatment of hyperlipemia in diabetic patients on dialysis with a physiological substance. Am J Nephrol 1991;11:32-6.. PubMed
- Agrati AM, Ambrosi G, Ferraro G, Palmieri. Gemfibrozil efficacy vs pantethine in dyslipoproteinemic patients: a controlled study. Curr Ther Res 1989;45:650-63.
- Rumberger, J. A., Napolitano, J., Azumano, I., Kamiya, T., and Evans, M. Pantethine, a derivative of vitamin B(5) used as a nutritional supplement, favorably alters low-density lipoprotein cholesterol metabolism in low- to moderate-cardiovascular risk No
- Hiramatsu, K., Nozaki, H., and Arimori, S. Influence of pantethine on platelet volume, microviscosity, lipid composition and functions in diabetes mellitus with hyperlipidemia. Tokai J.Exp.Clin.Med. 1981;6(1):49-57.
- McRae MP. Treatment of hyperlipoproteinemia with pantethine: A review and analysis of efficacy and tolerability. Nutrition Res 2005;25:319-333. DOI
- Cattin, L., Da Col, P. G., Fonda, M., Mameli, M. G., and Fergulio, G. A. Treatment of hypercholesterolemia with pantethine and fenofibrate; open randomized study on 43 subjects. Current Therapeutic Research 1985;38(Sep):386-395.
- Evans M, Rumberger JA, Azumano I, Napolitano JJ, Citrolo D, Kamiya T. Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC